Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
US7579001B2 · kind B2 · utility
9Cited by
4References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 4, 2006 |
| Grant date | Aug 25, 2009 |
| Priority date | — |
| Expiry date | Oct 4, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to reagents which modify the activity of TWEAK and their use as therapeutic agents for the treatment of immunological disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.